Most Recent Articles by Tori Rodriguez, MA, LPC
Increased implementation of integrated primary care could help to improve the availability of psychological treatment for this patient population.
It has been proposed that inflammation stemming from persistent pathogens may influence the development of mood disorders.
Rheuatology Advisor speaks with a psychologist about addressing mental health in patients with inflammatory arthritis.
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.
The prevalence of borderline personality disorder is estimated to between 15% and 20% in inpatient settings.
More Articles by Tori Rodriguez, MA, LPC
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Belief That Abortion Harms Women's Mental Health Appears Misinformed
- Models Derived From Electronic Health Records Effective in Predicting Suicide Risk
- Probiotics Effective in Reducing Rehospitalization for Patients With Mania
- Caffeine Sodium Benzoate Effective as Electroconvulsive Therapy Augmentation
- Personality Disorders Related to Adverse Outcomes in Bipolar Disorder
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Substance Abuse and Primary Psychosis: A Closer Look
- Preop Psychiatric Diagnoses Not Tied to Bariatric Surgery Outcomes in Teens
- Meds With Depression As Adverse Side Effect Commonly Used
- Predictors of Long-term Medication Adherence in Children With ADHD
- Antipsychotic Treatment Linked to Adiposity Changes in Youth
- Exposure to Maternal Hypertension May Up Risk for ASD, ADHD in Child